Here's the live share price of GlaxoSmithKline Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| GlaxoSmithKline Pharmaceuticals | -0.11 | -10.03 | 1.86 | 5.22 | -7.48 | 18.04 | 11.42 |
| Sun Pharmaceutical Industries | 0.46 | -4.05 | -9.83 | 3.77 | 6.44 | 15.76 | 16.08 |
| Divi's Laboratories | -3.72 | -1.63 | 24.10 | 46.36 | 37.56 | 35.20 | 11.10 |
| Torrent Pharmaceuticals | -1.69 | -5.24 | -8.41 | 10.59 | 30.12 | 33.97 | 24.19 |
| Zydus Lifesciences | 2.29 | 3.80 | -1.18 | 21.88 | 16.72 | 24.56 | 16.37 |
| Laurus Labs | 1.00 | 5.04 | 29.91 | 80.85 | 130.71 | 71.77 | 25.64 |
| Cipla | 2.20 | -2.01 | -7.25 | 8.73 | -14.39 | 4.63 | 8.09 |
| Dr. Reddy's Laboratories | 3.45 | 6.18 | -0.74 | 0.20 | -0.95 | 3.59 | 4.60 |
| Aurobindo Pharma | 2.01 | 0.61 | 7.98 | 21.77 | 51.00 | 22.59 | 18.45 |
| Mankind Pharma | -1.82 | 2.89 | -7.53 | 10.94 | -3.72 | 9.06 | 10.58 |
| Lupin | 0.89 | -4.68 | -21.37 | -16.24 | 0.96 | 17.81 | 15.90 |
| Glenmark Pharmaceuticals | 1.84 | -5.24 | -1.95 | -0.44 | 18.87 | 41.31 | 34.07 |
| Alkem Laboratories | -2.21 | -0.58 | -9.57 | -8.09 | -8.04 | 12.40 | 5.82 |
| Biocon | 0.72 | -7.74 | -19.13 | 0.30 | -1.31 | 11.42 | 0.52 |
| Abbott India | 1.56 | -0.43 | -5.80 | 0.23 | -12.59 | 5.03 | 3.98 |
| Gland Pharma | -0.41 | 6.14 | 24.09 | 74.11 | 57.97 | 24.75 | -4.01 |
| Ipca Laboratories | -0.68 | -0.95 | 2.05 | 30.20 | 47.19 | 25.75 | 9.69 |
| Anthem Biosciences | -3.67 | -10.76 | 11.92 | 15.33 | 8.43 | 4.81 | 2.86 |
| Ajanta Pharma | -2.25 | -4.17 | -2.69 | 16.34 | 39.47 | 24.18 | 17.91 |
| Emcure Pharmaceuticals | -0.76 | -7.87 | 2.51 | 11.66 | 35.01 | 10.58 | 6.22 |
Source: Dion Global
Over the last one year, GlaxoSmithKline Pharmaceuticals has declined 7.48% compared to peers like Sun Pharmaceutical Industries (6.44%), Divi's Laboratories (37.56%), Torrent Pharmaceuticals (30.12%). From a 5 year perspective, GlaxoSmithKline Pharmaceuticals has underperformed peers relative to Sun Pharmaceutical Industries (16.08%) and Divi's Laboratories (11.10%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 2,554.62 | 2,561.23 |
| 10 | 2,659.48 | 2,620.99 |
| 20 | 2,753.37 | 2,699.78 |
| 50 | 2,805 | 2,727.66 |
| 100 | 2,583.84 | 2,657.74 |
| 200 | 2,512.1 | 2,603.67 |
Source: Dion Global
In the latest quarter, GlaxoSmithKline Pharmaceuticals remained same as its previous close in promoter holding, while DII stake increased to 8.47%, FII holding fell to 4.75%, and public shareholding moved down to 11.77% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 12,022 | 2.17 | 3.67 |
Source: Dion Global
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Oct 13, 2026, 09:34 PM IST IST | GlaxoSmith. Pharma. - Board Meeting Intimation for To Consider, Approve And Take On Record The Un-Audited Financial Results |
| Oct 12, 2026, 10:00 PM IST IST | GlaxoSmith. Pharma. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Sep 15, 2026, 06:19 AM IST IST | GlaxoSmith. Pharma. - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot |
| Sep 15, 2026, 06:18 AM IST IST | GlaxoSmith. Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report |
| Sep 01, 2026, 09:02 PM IST IST | GlaxoSmith. Pharma. - Corrigendum To The Notice Of Postal Ballot Dated August 3, 2026 |
Source: Dion Global
GlaxoSmithKline Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 13/11/1924 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1924PLC001151 and registration number is 001151. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 3790.20 Cr. and Equity Capital is Rs. 169.41 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for GlaxoSmithKline Pharmaceuticals is ₹2,531.90 as on Oct 15, 2026.
The GlaxoSmithKline Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
The market cap of GlaxoSmithKline Pharmaceuticals is ₹42,891.91 Cr as on Oct 15, 2026.
Today’s highest and lowest price of GlaxoSmithKline Pharmaceuticals are ₹2,550.00 and ₹2,489.60.
The 52-week high/low is the highest and lowest price at which GlaxoSmithKline Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of GlaxoSmithKline Pharmaceuticals is ₹3,121.10 and 52-week low of GlaxoSmithKline Pharmaceuticals is ₹2,088.00 as on Oct 15, 2026.
The GlaxoSmithKline Pharmaceuticals has shown returns of -0.3% over the past day, -10.03% for the past month, 1.86% over 3 months, -7.48% over 1 year, 18.04% across 3 years, and 11.42% over 5 years.
P/E ratio of and PB ratio of GlaxoSmithKline Pharmaceuticals are 40.16 and 17.13 on Oct 15, 2026. While the company gives a dividend yield of 2.25 per annum.
Source: Dion Global